Regarding MTHFD1, besides its connection with survival outcomes in lung cancer patients with WT KRAS (Fig. 1a), its high expression was also associated to poorer survival in patients with KRAS/LKB1 co-mutations (Supplementary Fig. 1c). Here, MTHFD1 is linked to lung carcinoma.